West Oak Capital, LLC Abbott Laboratories Transaction History

West Oak Capital, LLC

  • $2.83 Billion
  • Q4 2024

A detailed history of West Oak Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, West Oak Capital, LLC holds 24,564 shares of ABT stock, worth $3.14 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
24,564
Previous 24,349 0.88%
Holding current value
$3.14 Million
Previous $27.8 Million -0.0%
% of portfolio
0.98%
Previous 0.98%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
BUY
$111.93 - $119.39 $24,064 - $25,668
215 Added 0.88%
24,564 $27.8 Million
Q3 2024

Oct 17, 2024
BUY
$100.07 - $118.13 $79,455 - $93,795
794 Added 3.37%
24,349 $27.8 Million
Q2 2024

Jul 24, 2024
BUY
$100.73 - $112.44 $88,340 - $98,609
877 Added 3.87%
23,555 $2.45 Million
Q1 2024

Apr 18, 2024
SELL
$109.52 - $120.96 $9,309 - $10,281
-85 Reduced 0.37%
22,678 $2.58 Million
Q4 2023

Jan 17, 2024
SELL
$90.19 - $110.4 $67,191 - $82,248
-745 Reduced 3.17%
22,763 $2.59 Million
Q3 2023

Oct 05, 2023
SELL
$95.53 - $114.62 $3,056 - $3,667
-32 Reduced 0.14%
23,508 $2.28 Million
Q2 2023

Jul 19, 2023
SELL
$100.78 - $112.29 $50,390 - $56,145
-500 Reduced 2.08%
23,540 $2.57 Million
Q1 2023

Apr 21, 2023
BUY
$96.86 - $114.01 $40,390 - $47,542
417 Added 1.77%
24,040 $2.43 Million
Q4 2022

Jan 05, 2023
SELL
$95.06 - $111.52 $110,459 - $129,586
-1,162 Reduced 4.69%
23,623 $2.59 Million
Q3 2022

Oct 28, 2022
SELL
$96.76 - $112.03 $10,450 - $12,099
-108 Reduced 0.43%
24,785 $2.4 Million
Q2 2022

Jul 11, 2022
SELL
$102.07 - $123.37 $61,241 - $74,022
-600 Reduced 2.35%
24,893 $2.71 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $39,907 - $48,664
-350 Reduced 1.35%
25,493 $3.02 Million
Q4 2021

Jan 12, 2022
SELL
$115.53 - $141.46 $93,925 - $115,006
-813 Reduced 3.05%
25,843 $3.64 Million
Q3 2021

Oct 07, 2021
SELL
$116.66 - $129.06 $73,495 - $81,307
-630 Reduced 2.31%
26,656 $3.15 Million
Q2 2021

Jul 20, 2021
BUY
$105.79 - $124.53 $22,215 - $26,151
210 Added 0.78%
27,286 $3.16 Million
Q1 2021

Apr 13, 2021
SELL
$108.84 - $128.23 $21,223 - $25,004
-195 Reduced 0.72%
27,076 $3.25 Million
Q4 2020

Jan 08, 2021
BUY
$105.0 - $114.42 $1,575 - $1,716
15 Added 0.06%
27,271 $2.99 Million
Q3 2020

Oct 09, 2020
SELL
$91.64 - $111.29 $129,670 - $157,475
-1,415 Reduced 4.94%
27,256 $2.97 Million
Q2 2020

Jul 06, 2020
SELL
$76.57 - $98.0 $17,611 - $22,540
-230 Reduced 0.8%
28,671 $2.62 Million
Q1 2020

Apr 07, 2020
BUY
$62.82 - $91.86 $16,019 - $23,424
255 Added 0.89%
28,901 $2.28 Million
Q4 2019

Jan 09, 2020
SELL
$78.51 - $87.4 $235,530 - $262,200
-3,000 Reduced 9.48%
28,646 $2.49 Million
Q3 2019

Oct 02, 2019
SELL
$81.84 - $88.74 $79,384 - $86,077
-970 Reduced 2.97%
31,646 $2.65 Million
Q2 2019

Jul 12, 2019
SELL
$72.88 - $85.0 $13,118 - $15,300
-180 Reduced 0.55%
32,616 $2.74 Million
Q1 2019

Apr 03, 2019
SELL
$66.22 - $80.06 $23,772 - $28,741
-359 Reduced 1.08%
32,796 $2.62 Million
Q4 2018

Jan 08, 2019
SELL
$65.56 - $74.27 $23,929 - $27,108
-365 Reduced 1.09%
33,155 $2.4 Billion
Q3 2018

Oct 04, 2018
SELL
$60.81 - $73.36 $243 - $293
-4 Reduced 0.01%
33,520 $2.46 Billion
Q2 2018

Jul 06, 2018
SELL
$57.57 - $63.54 $52,964 - $58,456
-920 Reduced 2.67%
33,524 $2.04 Billion
Q1 2018

Apr 05, 2018
SELL
$56.27 - $63.62 $149,734 - $169,292
-2,661 Reduced 7.17%
34,444 $2.06 Billion
Q4 2017

Jan 05, 2018
SELL
$53.68 - $57.47 $79,178 - $84,768
-1,475 Reduced 3.82%
37,105 $2.12 Billion
Q3 2017

Oct 10, 2017
BUY
$48.06 - $53.64 $1.85 Million - $2.07 Million
38,580
38,580 $2.06 Billion

Others Institutions Holding ABT

# of Institutions
3,224
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track West Oak Capital, LLC Portfolio

Follow West Oak Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email